To identify small molecules that reprogram T H 17 differentiation towards iT reg cell fate, we screened 10,000 small molecules using CD4 + naive T cells from IL-17F-RFP/FOXP3-GFP mice cultured under optimal T H 17 differentiation conditions 9 (Extended Data Fig. 1a) . A small molecule, (aminooxy)acetic acid (AOA), was found to reprogram T H 17 induction to iT reg cells in a dose-dependent manner (Fig. 1a and Extended Data Fig. 1b). Notably, treatment with AOA increased the phosphorylation of AMPKα in T H 17 cells, characteristic of T reg cells, without affecting mechanistic target of rapamycin (mTOR) activity and c-Myc expression (Extended Data Fig. 1c ). In addition, AOA-treated T H 17 cells had a similar slow proliferation rate to iT reg cells (Extended Data Fig. 1d) ; however, the effect of AOA on cell proliferation did not impair cell survival or the ability of these T cells to differentiate into iT reg cells under T H 17 cell differentiation conditions (Fig. 1a, b and Extended Data Fig. 1b, f). Notably, AOA dose-dependently promoted the induction of iT reg cells, even under iT reg cell culture conditions ( Fig. 1c and Extended Data Fig. 1e ), suggesting that AOA may directly regulate FOXP3 expression and the iT reg cell program. Furthermore, AOA selectively reduced the mRNA levels of Il17a and Il17f, but not Rorc, in T H 17 cells and promoted the transcription of Foxp3 in T H 17 and iT reg cells (Fig. 1b, d ).
a reductive amination, in which the redox balance of the reaction is maintained by concomitant conversion of glutamate (nitrogen donor) into α -ketoglutaric acid (α -KG) 10, 11 . Thus, the pyridoxal-5′ -phosphate/ glutamate-dependent transaminase(s) involved in T-cell differentiation can be deduced by measuring stable isotopic label accumulation into various amino acids for differentiating T H 17 cells or iT reg cells fed with [ (Fig. 1e ). These data suggest that a primary fate of the amino group of glutamate in differentiating T H 17 cells and iT reg cells was for biosynthesis of aspartic acid catalysed by glutamate oxaloacetate transaminase 1 and 2 (GOT1 and GOT2), and also that GOT1 and GOT2 serve as the major transaminases catalysing the conversion of glutamate into α -KG in these cells. Consistently, GOT1 was the only transaminase highly and differentially expressed in T H 17 and iT reg cells (Fig. 1f) , further suggesting an important mechanistic link for GOT1 activity in the fate determination of T H 17 cell differentiation. Short hairpin RNA (shRNA) knockdown of GOT1 in differentiating T H 17 cells inhibited T H 17 cell differentiation and reciprocally increased iT reg cell differentiation (Fig. 1g, h ). The effect of Got1 shRNA could not be further increased by AOA (Extended Data Fig. 2d ), also confirming the suggestion that GOT1 is the main target of AOA during T H 17 cell differentiation.
To explore how GOT1-dependent transamination regulates T H 17 cell differentiation, we profiled intracellular metabolite levels after AOA treatment by LC-MS metabolomics in differentiating T H 17 and iT reg cells (day 2.5). Differentiating T H 17 cells showed a slight increase in several tricarboxylic acid (TCA) cycle intermediates, such as α -KG, succinate, fumarate, malate and citrate, compared with differentiating iT reg cells, and their abundance was partially reduced by AOA in both differentiating conditions (Fig. 2a and Extended Data Fig. 3) . Notably, among all of the metabolites detected, 2-hydroxyglutarate (2-HG), which is the direct product of error-prone dehydrogenase activity on the α -KG substrate, exhibits the most significantly increased level in T H 17 cells relative to iT reg cells (Fig. 2a) . Differentiating T H 17 cells maintained approximately 5-10-fold greater levels of 2-HG compared to iT reg cells along the differentiation timeline (Fig. 2a and Extended Data Fig. 3b) , with intracellular levels quantified to be approximately 0.2 mM. Indeed, AOA reduced the steady-state levels of 2-HG by 75% and 50% in differentiating T H 17 and iT reg cells, respectively (Fig. 2a and Extended Data Fig. 3 ), suggesting that 2-HG synthesized from transamination-driven α -KG in differentiating T H 17 and iT reg cells contributes significantly to the total amount of 2-HG. Notably, AOA treatment did not affect the l-lactic acid level in cells, indicating that AOA treatment did not affect glycolysis (Extended Data Fig. 3 ).
To confirm further that the conversion of total cellular glutamate into α -KG drives altered 2-HG levels, differentiating T H 17 and iT reg cells were cultured with a uniformly 13 C-labelled glutamine ([U-13 C] glutamine) for 4 h, and then intracellular metabolites and isotopologues were analysed by LC-MS (Fig. 2b) . With more than 80% of the intracellular glutamine pool labelled, the fractional labelling of [U- C]α -KG and TCA cycle intermediates was higher in T H 17 cells than in iT reg cells (Fig. 2c) , suggesting that more glutamine/glutamate carbon contributes to the TCA cycle and 2-HG synthesis in differentiating T H 17 cells than in iT reg cells. Notably, newly synthesized 2-HG was more than 30-fold higher in T H 17 cells than in iT reg cells, whereas newly synthesized α -KG is around 3-fold higher in T H 17 cells than in iT reg cells (Fig. 2d) . As expected, the de novo synthesis of both α -KG and 2-HG in iT reg and T H 17 cells was inhibited by AOA, and this provides the metabolic confirmation for the decrease in the total pool as a function of AOA treatment (Fig. 2d) .
To determine further the functional importance of metabolites downstream of glutamate and α -KG in specifying T H 17 and iT reg cell cell induction under iT reg cell conditions. d, Foxp3 mRNA expression from cells in c. e, GOT1 and GOT2 are the major transaminases catalysing glutamate flux into α -KG. Data are mean ± s.d. of three replicates from a representative experiment. f, GOT1 is highly upregulated under T H 17 cell conditions. g, shRNA knockdown of GOT1 (using shGot1-1 and shGot1-2) reduced T H 17 cell differentiation and reciprocally increased iT reg cell differentiation. shControl denotes a non-targeting shRNA control. h, Statistics of cell populations from g. i, The effect of GOT1 knockdown on gene expression. In a, c and g, representative flow cytometry data from five (a) or three (c and g) independent experiments are shown. In h, a and c (right panels), data are mean ± s.d. of five (a, right) or three (c, right, and h) independent experiments. In b, d, f and i, data are mean ± s.d. of three replicates from a representative experiment of three independent experiments. NS, not significant. * P < 0.05; * * P < 0.01; * * * P < 0.001 by Student's t-test.
Letter reSeArCH fate, cell-permeable α -KG, 2-HG, succinate, fumarate, malate, citrate, N-acetyl-cysteine (NAC) and glutathione (GSH) were individually added to AOA-containing T H 17 or iT reg cell culture conditions. Among all of the metabolites examined, only cell-permeable α -KG and (R)-2-HG rescued the inhibitory effect of AOA on T H 17 cell differentiation or reversed its enhancing effect on iT reg cell differentiation (Fig. 2e, f and Extended Data Fig. 4 ). Moreover, cell-permeable (R)-2-HG, but not α -KG (the precursor of 2-HG), directly promoted T H 17 cell differentiation (in the absence of AOA) by upregulating the expression of Il17a and Il17f and downregulating the expression of Foxp3 in a dose-dependent manner without affecting cell survival or proliferation ( Fig. 3a and Extended Data Fig. 5a, c, d ), suggesting that 2-HG regulates T H 17 cell differentiation independently of cell proliferation. Similarly, cell-permeable (R)-2-HG, but not α -KG, inhibited Foxp3 expression under iT reg cell conditions (Fig. 3c , Extended Data Fig. 5b) . A possible distinction between 2-HG and α -KG in normal T H 17 and iT reg cell differentiation in the absence of AOA is that the generation of 2-HG, but not α -KG, may represent a rate-limiting step in glutamate metabolism that dictates the fate of differentiating T cells. These results showed that central carbon metabolism involving α -KG and its downstream metabolites (that is, 2-HG) is not simply a metabolomics phenomenon, but rather is a functional effector of the naive T-cell specification and its response to AOA.
2-HG has been shown to be produced by wild-type IDH1-and IDH2-mediated metabolism 12, 13 . Consistently, IDH1 and IDH2 are highly expressed in differentiating T H 17 cells (Extended Data Fig. 6a, b and data not shown). Knockdown of both IDH1 and IDH2 in differentiating T H 17 cells decreased the production of 2-HG, reduced Il17a and Il17f expression, and reciprocally increased the expression of Foxp3 (Fig. 3e, f and Extended Data Fig. 6c ) without affecting Rorc mRNA expression or HIF1α protein expression (Extended Data Fig. 6c, f) . The effect of IDH1/2 knockdown on T H 17 cell differentiation can be rescued by adding exogenous 2-HG (Extended Data Fig. 6e ). The data thus suggest that α -KG and 2-HG that accumulated under T H 17 cell differentiation conditions promote further T H 17 cell differentiation.
(R)-2-HG suppressed Foxp3 transcription in both T H 17 and iT reg cells, and increased the transcription of Il17a and Il17f, but not Rorc, in differentiating T H 17 cells, indicating that (R)-2-HG might indirectly promote T H 17 cell differentiation by FOXP3 downregulation 14 ( Fig. 3a-d 
FOXP3
+ cells (Extended Data Fig. 7a ), confirming that TET1 and TET2 also control FOXP3 expression during T H 17 cell differentiation. Consistently, 2-HG treatment promoted T H 17 cell differentiation in wild-type T cells, but the effect was largely abrogated in Tet1 and Tet2 double-knockout T cells (Extended Data Fig. 7a ). In addition, double knockout of Tet1 and Tet2 partially diminished the effect of AOA on T H 17 cell differentiation (Extended Data Fig. 7b ), possibly because all three TET proteins function redundantly to regulate FOXP3 expression 15, 16 . These data collectively suggest that 2-HG and AOA regulate T H 17 cell differentiation at least in part by targeting TET1 and TET2. Consistently, a recent study also showed that double knockout of Tet1 and Tet2 in T cells resulted in unstable T reg cells that were prone to conversion into T H 17 cells, and caused inflammation in several organs 15 . Notably, a reduced concentration of TGFβ (and therefore reduced recruitment of TET1 and TET2 to the Foxp3 locus 15 ) largely abrogated the promoting effect of Tet1 and Tet2 knockout on T H 17 cell differentiation, further confirming the role of TET1 and TET2 in FOXP3 expression during T H 17 cell differentiation (Extended Data Fig. 7c) .
To further investigate the role of 2-HG and TET proteins in T H 17 cell differentiation, we examined the methylation status of the Foxp3 Percentage of cells . Surprisingly, we found that these regions are also hypomethylated in differentiating T H 17 cells, similar to iT reg cells, but are hypermethylated in fully differentiated T H 17 cells (Fig. 3g) . Notably, 2-HG markedly increased the methylation levels of these regions in both differentiating T H 17 cells and iT reg cells (Fig. 3g) . Conversely, knockdown of IDH1 and IDH2 reduced methylation levels at the Foxp3 promoter and conserved non-coding sequence 2 (CNS2) region (Extended Data Fig. 6d) . Similarly, AOA treatment markedly decreased the methylation level at the Foxp3 gene locus in both T H 17 and iT reg cell cultures (Fig. 3h) . Genome-wide distribution of 5-hydroxymethylcytosine (5hmC) and 5-methylcytosine (5mC) were then analysed by hydroxymethylated or methylated DNA immunoprecipitation followed by high-throughput sequencing (hMeDIP-seq or MeDIP-seq, respectively). In total, 330,582 peaks were enriched with 5hmC in T H 17 cells. 2-HG treatment resulted in a reduced 5hmC signal at 17,676 peaks, among which 3,402 sites also exhibited an increased 5mC signal, including the Foxp3 locus ( Fig. 3i and Extended Data Fig. 8a, b) . By contrast, AOA treatment increased the 5hmC signal at 11,896 sites, among which 1,643 peaks exhibits reduced 5mC signals (Extended Data Fig. 8c, d ). Consistently, AOA treatment increased the 5hmC signal at both the Foxp3 promoter and the CNS2 region, and decreased the 5mC signal at the Foxp3 promoter ( Fig. 3j and Extended Data Fig. 8c, d ) but not at the CNS2 region, probably because the changes were subtle and not detectable as the CNS2 region is always hypermethylated in iT reg cells (70-80%) 17 . Notably, neither 2-HG nor AOA treatment changed the 5hmC or 5mC signal at other important lineage-specific gene loci, such as Ifng, Il4, Il5, Il10, Il13, Rorc and Tbx21 (Extended Data Fig. 8 ). Notably, both AOA and 2-HG treatment affected the 5hmC and 5mC signals at i, j, The effect of 2-HG or AOA on hydroxymethylation/methylation at the Foxp3 locus examined by (h)MeDIP-seq. 5hmC peaks (blue) or 5mC peaks (red) at the Foxp3 locus are shown. In g-j, male mice were used owing to X-chromosome inactivation. Flow cytometry data from a representative experiment are shown in a, c and f. The experiments were repeated at least three times. Data in a, c and f (right panels) are mean ± s.d. of three independent experiments. Data in e (n = 12) are mean ± s.d. from four independent experiments. Data in b and d are mean ± s.d. of three replicates from a representative experiment of three independent experiments. * P < 0.05; * * P < 0.01; * * * P < 0.001 by Student's t-test. 121 sites (97 genes, including non-coding RNAs), many of which are direct FOXP3 targets, such as Foxp1 and Bach2 (Extended Data Fig.  8e , f, Supplementary Data 2), indicating that changes in 5hmC and 5mC at these targets may be caused indirectly by FOXP3 expression. These epigenetics analyses, together with gene expression data, strongly suggest that AOA and 2-HG regulate T H 17 cell differentiation indirectly by altering the expression of Foxp3, but not of other T-lineage-related genes.
To examine the functional relevance of our findings, experimental autoimmune encephalomyelitis (EAE) was induced as described 18 . AOA or control vehicle was injected daily intraperitoneally after most mice had developed apparent diseases. Notably, the administration of AOA caused a significant recovery from EAE diseases in this therapeutic disease model (Fig. 4a ). In addition, the total number of mononuclear cells infiltrating into the central nervous system was markedly reduced in AOA-treated mice compared to control mice (Extended Data Fig. 9d ). The treatment of AOA significantly reduced the percentage of IL-17-producing T cells and increased the percentage of FOXP3
+ T cells (P < 0.05) without affecting the percentage of IFNγ + cells (P > 0.05) in the central nervous system (Fig. 4b, c) . The ratio of FOXP3 + cells to IL-17 + cells is much higher in AOA-treated mice than in control mice (Fig. 4c ). To investigate further the physiological importance of GOT1 in vivo, an adoptive transfer model using CD4 naive T cells from 2D2 mice (constitutively expressing MOG 35-55 specific T-cell antigen receptors 19 ) was performed. The cells undergoing T H 17 cell differentiation were infected with a virus containing Got1 shRNA or control shRNA and Thy1.1 (CD90.1), and the infected cells were then transferred into wild-type mice. In this T H 17-polarized transfer EAE model, disease severity plus the total number of mononuclear cells infiltrating into the central nervous system were significantly reduced in mice receiving GOT1-knockdown cells compared with those receiving control-shRNA-infected cells (Fig. 4d , e, Extended Data Fig. 9a, d ). The percentage of IL-17-producing T cells and FOXP3 + T reg cells infiltrating into the central nervous system were significantly decreased and increased, respectively by GOT1 knockdown, whereas IFNγ + T cells were not readily detectable (Fig. 4f , g, and Extended Data Fig. 9 ). Our study thus demonstrates that selectively targeting the glutamate metabolic pathway could alter the balance of T H 17 and T reg cells both in vitro and in vivo, and may represent a new strategy for addressing T H 17-mediated autoimmune diseases.
In summary, we have shown that increased transamination via GOT1 leads to a much greater accumulation of 2-HG in differentiating T H 17 cells than in iT reg cells, and this promoted the methylation of the Foxp3 gene locus and silenced Foxp3 gene expression. Notably, we found that 2-HG levels in differentiating T H 17 cells (for example, 0.1-0.4 mM) were much lower than that in human cancer cells containing IDH1 and IDH2 mutations (≥ 1 mM). Nonetheless, endogenous 2-HG accumulations under T H 17 conditions and experiments with exogenously added 2-HG in T H 17 cell culture correlate well with hypermethylation of the Foxp3 gene locus and reduced mRNA and protein levels of FOXP3 in fully differentiated T H 17 cells, suggesting that different cell types may exhibit differential sensitivity to 2-HG levels. Manipulating a single step in a glutamate metabolic pathway could change T H 17 cell fate by affecting methylation of the Foxp3 gene locus, and ameliorate mouse EAE disease by regulating the T H 17 and iT reg cell balance, highlighting the importance of cellular metabolism in the determination of T-cell fate.
Online Content Methods, along with any additional Extended Data display items and Source Data, are available in the online version of the paper; references unique to these sections appear only in the online paper. Nat. Immunol. 13, 907-915 (2012 shControl (n = 7) shGot1-1 (n = 9) *** *** *** *** *** J. Exp. Med. 197, 1073 -1081 (2003 .
Supplementary Information is available in the online version of the paper. ) were sorted from IL-17F-RFP/FOXP3-GFP mice, which were characterized previously or wide-type C57BL/6 mice (6-10-week-old male or female mice were used unless specified). Approximately 0.4 million cells were plated into 48-well-plates coated with anti-mouse CD3 (clone 145-2C11, eBioscience) (2 μ g ml
) and anti-mouse CD28 (clone 37.51, eBioscience) (1 μ g ml
−1
). The differentiation conditions for T cells are as followed: 0.5 ng ml −1 (or indicated) TGFβ , 200 U ml −1 mouse IL-2, 2 μ g ml −1 anti-IFNγ and 2 μ g ml −1 anti-mouse IL-4 for iT reg , 2.5 ng ml −1 TGFβ , 10 ng ml −1 mouse IL-1β , 10 ng ml −1 mouse IL-6, 10 ng ml −1 mouse IL-23, 2 μ g ml −1 anti-mouse IFNγ , and anti-mouse IL-4 for T H 17. All the cytokines are from R&D systems. The cells were supplemented with new medium at day 4. For cases in which small-molecule compounds were present, fresh medium containing the same concentration of compounds was used. When necessary, the individual metabolite was added into the T-cell culture 6 h after initial cell plating. On day 6, the cells were analysed for IL-17F-RFP and FOXP3-GFP or the cells were collected and restimulated for 4-6 h with phorbol myristate acetate (PMA), ionomycin, and Golgi-stop for intracellular staining in absence of indicated compounds. Antibodies. Anti-IDH2 was from Abcam (ab131263), anti-IDH1 was from Cell Signaling Technology (8137S), and anti-HIF1α was from Novus Biologicals (NB100-105). N-d 5 ) was added into samples, and the peak value for each metabolite was normalized to an extraction standard. The data were transformed into log 2 and clustered. Cell extracts obtained as described above were analysed for relative abundance of Negative mode metabolomics. Cell extracts obtained as described above were analysed for relative abundance of metabolites by LC-MS using scheduled selective reaction monitoring (SRM) for each metabolite of interest, with the detector set to negative mode 20 . Before injection, dried extracts were reconstituted in LC-MS grade water. Liquid chromatogrpahy separation was achieved by reverse-phase ion-pairing chromatography as described 22 . Amino acid profiling. The U-HPLC system consisted of a Thermo Fisher Scientific U-HPLC pumping system, coupled to an autosampler and degasser. Chromatographic separation of the intracellular metabolites was achieved by usage of a reversed phase Atlantis T3 (3 μ m, 2.1 mm ID × 150mm) column (Waters) and by implementation of a gradient elution program. The elution gradient was carried out with a binary solvent system consisting of 0.1% formic acid and 0.025% heptafluorobutyric acid in water (solvent A) and in acetonitrile (solvent B) at a constant flow rate of 400 μ l min −1
. The linear gradient employed was as follows: 0-4 min increase from 0 to 30% B, 4-6 min from 30 to 35% B, 6-6.1 min from 35 to 100% B and hold at 100% B for 5 min, followed by 5 min of re-equilibration. The column oven temperature was maintained at 25 °C and sample volumes of 10 μ l were injected. HRAM data were acquired using a QExactive Orbitrap mass spectrometer (Thermo Fisher Scientific), which was equipped with a heated electrospray ionization source (HESI-II), operated in positive mode. Ionization source working parameters were optimized; the heater temperature was set to 300 °C, ion spray voltage was set to 3,500 V. An m/z scan range from 70 to 700 was chosen and the resolution was set at 70,000. The automatic gain control (AGC) target was set at 1 × 10 6 and the maximum injection time was 250 ms. Instrument control and acquisition was carried out by Xcalibur 2.2 software (Thermo Fisher Scientific). Methylation analysis by bisulfite sequencing. The method is the same as described. In brief, genomic DNA was purified with the Blood and Cell Culture DNA Midi Kit (Qiagen). Bisufite conversion of genomic DAN was performed using EpiTect Bisulfite kit (Qiagen), according to the manufacturer's instructions. The primers used to amplify the Foxp3 promoter and its intronic CpG island are described in the Supplementary Information. The PCR product was run on 2% agarose, purified and cloned using TOPO TA Cloning Kit with PCR4. Clones are picked for Sanger sequencing. Retrovirus preparation and T-cell infection. shRNAs (synthesized DNA oligonucleotides) after annealing were cloned into PMKO.1-GFP retrovirus or PMKO.1-Thy1.1-mRFP vector. The plasmids and pCL-ECO (1:1) were transfected into 293T cells (ATCC, CRL-3216; all cells were tested for mycoplasma contamination) with Fugene HD4 (Promega). The medium was changed 6 h after transfection, and the cells were further cultured for 48-72 h. The supernatant was then collected and filtered using 45-μ m filters. The supernatant containing the viruses was added into pre-activated CD4 T cells (20 h after initial plating). The cells were spin-infected at 1,000g for 2 h and cultured in an incubator for another 2 h. The cells were washed and cultured under T H 17 cell conditions for an additional 4 days. New medium was added if necessary. At day 5, the cells are collected for sorting GFP + and GFP − cells. Sorted cells were further cultured until day 6, and re-stimulated for intracellular staining or mRNA analysis, as described above. Mouse EAE model. EAE was induced by immunizing mice (12 weeks old, 5-6 C57BL/6 mice per group) twice with 300 μ g of MOG 35-55 peptide (amino acids 35-55; MEVGWYRSPFSROVHLYRNGK) emulsified in complete Freund's adjuvant, followed by pertussis toxin injection and analysed as described 18 . The disease scores were assigned on a scale of 0-5 as follows: 0, none; 1, limp tail or waddling gait with tail tonicity; 2, wobbly gait; 3, hind limb paralysis; 4, hind limb and forelimb paralysis; 5, death. When the disease phenotype is very obvious (average score > 1), PBS or AOA (750 μ g per mouse) was intraperitoneally injected every day (mice were randomly assigned to treatment groups, and scored in a blinded manner). After 8 days of administration of AOA or PBS, the mice were anaesthetized, and cells infiltrated into brain and spinal cord were collected for analysis. For adoptive transfer EAE, CD4 naive T cells isolated from 2D2 mice (https://www.jax.org/strain/006912) were cultured under T H 17 cell conditions for 20 h, and then the cells were infected with virus containing shGot1 or control shRNA and a cell surface protein, Thy1.1 + (which does not express in C57BL/6 background mice). At the end of the differentiation, the cells were purified, and 6 × 10 7 cells were intraperitoneally injected into wild-type C57BL/6 recipient mice (8-10-week-old female mice). The recipient mice were irradiated with sublethal X-ray (5 Gy) before cells injection. PTX (500 ng per mouse) was intraperitoneally injected later on the day of transfer and two days later. The disease was scored daily thereafter as above. Mice were randomly assigned to treatment groups, and scored in a blinded manner. Experimental groups were unblinded to treatment assignment at the end of the experiments to ensure experimenter bias was not introduced. At the end of experiment, the mice were euthanized for analysis of the T cells infiltrated into the central nervous system. Mice that did not develop symptoms of EAE were not excluded from the analysis. Power analysis was used to calculate the sample size. 4 mice per group is enough for calculation, here we used 5-6 in active EAE, or 7-9 mice in adoptive transfer EAE to get a more confident dataset. When indicated, the statistical significance was determined by Student's t-test (* P < 0.05; * * P < 0.01; * * * P < 0.001). All animal work was approved by the institutional IACUC committee. 
CD4-Cre
+ mice. 2D2 mice (https://www. jax.org/strain/006912) were purchased from Jax. MeDIP-seq/hMeDIP-seq. DNA was purified from differentiating T H 17 cells (in the absence or presence of dimethyl (R)-2-HG), or T H 17 cells at the end of differentiation (in the absence or in presence of AOA), and sheared into 200-500-bp fragments using a Covaris S2 sonicator. DNA fragments were then end-repaired, adenylated, and adaptor added using the Nextflex ChIP-seq preparation kit (Bio Scentific) following the manufacturer's protocol. The ligated DNA was then denatured into single-stranded DNA for chromatin immunoprecipitation (ChIP). The ChIP was done by incubating the DNA with anti-5mC or 5hmC (from Active Motif) following the manufacturer's protocol. After ChIP, the eluted DNA was PCR amplified and sequenced on Hiseq-2500. Data analysis for (h)MeDIP-seq. Raw FASTQ Reads are trimmed using the fastq-mcf program to remove any Illumina adaptor sequence. Trimmed reads are aligned to the genome assembly of Mus musculus reference genome (NCBI37/ mm9) using Bowtie2 1 . 5hmC and 5mC peak identification was performed with MACS 2 using non-duplicate reads from each immunoprecipitation sample and its corresponding input control sample. Parameters are as follows: effective genome size = 1.87 × 10 9 ; band width = 200; ranges for calculating regional lambda are: peak_region, 1,000, 5,000, 10,000; and Benjamini-Hochberg q-value cutoff = 0.01 to identify confident peaks. Read counts of all peak regions were extracted from each samples by bedtools multicov 3 and used for further analysis of quantitative changes. Peak regions with a greater than 30 read count in all 5hmC sample or 10 in 5mC samples are kept. Each region for each sample is scored by the read count in this region normalized to the total number of mapped reads in each sample. The difference is computed as peak region intensity between samples as log 2 fold change. Peak region annotation is performed with Homer tools suite to identify genomic features and associated genes based on distance to the nearest transcription start site. Peak region intensities of larger than 2-fold difference for 5hmC or 1.8-fold for 5mC were highlighted by scatter plot. Normalized pileup files are converted to bigwig (http://genome.ucsc.edu/goldenpath/help/bigWig.html) for visualization in IGV [26] [27] [28] . Data availability. The NCBI SRC accession number for the MeDIP-seq and hMeDIP-seq experiments reported in this manuscript is BioProject PRJNA360149. were collected for analysis of phosphorylated AMPKα 1 (p-AMPKα 1), the mTOR downstream signalling proteins S6K and 4E-BP1, and c-Myc and β -actin. Dimethylsulfoxide (DMSO) was used as a control. d, The effect of AOA on the proliferation of T H 17 cells. CD4 naive T cells were labelled with CellTrace Violet, and then cultured under T H 17 or iT reg cell conditions (which were the same as T H 17 cell conditions except without IL-1β , IL-6 and IL-23). At the end of experiment, the cells were analysed by intracellular staining. e, AOA promoted iT reg cell differentiation. f, AOA did not affect the survival of T H 17 cell culture. The cells were differentiated under T H 17 cell conditions with or without AOA. At the end of the differentiation, 7-AAD was added and the cells were immediately collected for analysis. 15 N]α -glutamine for 4 h. The cells were collected for intracellular metabolites analysis. The ratios of 15 N-labelled aspartate, glycine, alanine and serine to their total respective amino acid pools were calculated. c, AOA, as a pan-transaminase inhibitor, inhibited de novo synthesis for several amino acids (via transamination) in both cell types in addition to aspartate. The ratio of [
15 N]amino acid to [ 15 N]glutamate was calculated, and this ratio was further normalized to that in T H 17 cells to demonstrate that AOA inhibited de novo synthesis for several amino acids. Our rescue results clearly showed (in Fig. 2f, g ) that dimethyl-α -KG can largely rescued the effect of AOA on both T H 17 and iT reg cell differentiation. Thus, from a metabolic perspective, the effects of AOA can be largely attributed to its inhibitory effect on α -KG formation (carbon metabolism), rather than its inhibitory effect on amino acid synthesis (nitrogen metabolism). Therefore, we focus on carbon metabolism of glutamate in this study. d, GOT1 is the main target for AOA in T H 17 cells. Differentiating T H 17 cells were infected with retrovirus containing shRNA against Got1 or control shRNA. The GFP + cells were then purified on day 3, and further cultured under T H 17 cell conditions with/or without AOA. At the end of differentiation (day 6), the cells were collected for analysis of FOXP3 and IL-17 by intracellular staining. It is clear that AOA can further inhibit T H 17 cell differentiation; however, the effect is subtle and supports the conclusion that GOT1 is the main target for AOA under T H 17 conditions. Data in b and c are mean At the end of the differentiation (day 5), the cells were directly analysed for FOXP3-GFP. Representative flow cytometry data (left panels) are from three independent experiments. Bar graphs are mean ± s.d. of three independent experiments. * * P < 0.01; * * * P < 0.001 by Student's t-test. (shControl) . At the end of the differentiation (day 6), GFP + cells were collected for DNA methylation analysis of the Foxp3 promoter and its intronic CpG island by bisulfate sequencing. Filled circles denote methylated cytosine; open circles denote demethylated cytosine. Male mice were used owing to X-chromosome inactivation. e, Knockdown of IDH1 and IDH2 suppressed T H 17 cell differentiation, and this can be reversed by addition of cell permeable (R)-2-HG. Cell permeable (R)-2-HG was added to differentiating T H 17 cells at 6 h. The cells were infected with retrovirus containing shRNA. GFP + cells were purified at day 3 for further culture under T H 17 cell conditions, and cell permeable (R)-2-HG was added to the culture until the end of the experiment. Cells were then collected for analysis of FOXP3 and IL-17. f, Knockdown of IDH1 and IDH2 has minimal effect on HIF1α expression. Differentiating T H 17 cells were infected with retrovirus containing Idh1 shRNA, Idh2 shRNA and Idh1 plus Idh2 shRNA or control shRNA. Cells were then analysed for IDH1, IDH2 and HIF1α expression. Data in a-c are mean ± s.d.(n = 3) of three technical replicates from a representative experiments of three experiments. Data in e (n = 3) are mean ± s.d. of three independent experiments. * P < 0.05; * * P < 0.01; * * * P < 0.001 by Student's t-test. were analysed (gated on Thy1.1 + cells), and representative flow cytometry data are shown. c, Statistics for the T cells infiltrated into the central nervous system (CNS). Data in a and c are mean ± s.d. * P < 0.05; * * P < 0.01; * * * P < 0.001 by Student's t-test. d, Quantification of the numbers of cells infiltrated into the central nervous system regions. e, Schematic of our mechanistic model. The cell number in Fig. 4d -g was retrieved from flow cytometry data. Although we did not count the number of individual populations, we noticed that the total number of cells infiltrating into the central nervous system was reduced by Got1 shRNA; fewer than 50,000 cells were recovered from the Got1 shRNA group, whereas more than 50,000 cells were recovered from control mice. Thus, for mice receiving T cells infected with shRNA control virus, the cell number was calculated from a total of 50,000 live cells acquired by flow cytometry (this group of mice had a much higher number of total infiltrated cells, and we stopped acquiring cells after the total number reached the 50,000 threshold). Mice receiving T cells infected with Got1 shRNA virus had fewer cells infiltrated into the central nervous system, and collected cells did not reach the 50,000 threshold during flow cytometry; therefore, the cell numbers represent all of the cells infiltrated into the central nervous system. Despite the low accuracy, Got1 shRNA decreased the total absolute number of cells infiltrated into the central nervous system. For two other EAE experiments, cell numbers were counted immediately after isolating cells from the central nervous system.
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